瑞康医药 (002589.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(瑞康医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度每股收益(元) ----1.00---
 单季度销售毛利率(%) 14.0011.0015.00-11.0015.0018.0017.00
 单季度销售净利率(%) -1.001.001.00-133.00-1.002.00
 单季度净资产收益率ROE(%) ----31.00--1.00
 单季度总资产净利率ROA(%) ----9.00---
单季度财务摘要:
 单季度营业总收入(元) 2,025,130,032.002,006,904,830.002,073,027,669.001,414,560,935.003,345,646,406.003,457,573,371.004,093,497,043.00
 单季度营业总成本(元) 2,026,222,486.002,102,077,798.002,081,916,966.001,883,478,147.003,390,031,881.003,393,930,497.003,955,744,878.00
 单季度营业收入(元) 2,025,130,032.002,006,904,830.002,073,027,669.001,414,560,935.003,345,646,406.003,457,573,371.004,093,497,043.00
 单季度营业利润(元) -13,727,857.0031,854,242.0032,977,741.00-1,912,653,450.0023,948,196.0020,796,396.00151,289,600.00
 单季度利润总额(元) -33,843,624.0034,167,835.0032,936,582.00-1,928,335,375.0020,325,360.0018,096,748.00146,001,703.00
 单季度净利润(元) -13,754,412.0011,602,984.0029,983,448.00-1,884,835,335.007,360,891.0039,422,633.0098,579,158.00
 单季度归属母公司股东的净利润(元) -11,447,151.009,507,705.0021,159,565.00-1,892,736,806.002,094,084.0016,254,275.0042,736,596.00
 单季度经营活动产生的现金流量(元) 153,814,431.00103,089,951.0075,590,663.00197,527,440.0048,619,576.00145,774,740.00131,152,117.00
 单季度投资活动产生的现金流量(元) -136,350,144.00328,413,446.00247,712,309.00437,392,332.00506,590,889.00-75,663,958.00-275,361,879.00
 单季度筹资活动产生的现金流量(元) -481,029,635.00-404,819,996.0057,982,032.00-1,129,954,770.00-652,136,634.00285,888,729.0031,077,571.00
 单季度现金及现金等价物净增加(元) -463,565,348.0026,683,401.00381,285,004.00-495,030,982.00-96,926,169.00355,999,511.00-113,132,191.00

前瞻产业研究院